Table 3.
Association between the presence of inflammatory cells and clinical factors
| Inflammatory cell | Odds ratio | 95% CI | p value | FDR-adjusted |
|---|---|---|---|---|
| Neutrophil | ||||
| Time after biopsy | 1 | 0.955–1.043 | 0.992 | 0.994 |
| Carrier material | 4.044 | 1.163–18.96 | 0.043* | 0.462 |
| ER/PR+ | 0.351 | 0.103–1.232 | 0.094 | 0.596 |
| HER2+ | 1.286 | 0.256–5.149 | 0.735 | 0.982 |
| Eosinophil | ||||
| Time after biopsy | 1.005 | 0.968–1.043 | 0.809 | 0.982 |
| Carrier material | 4.135 | 1.516–12.353 | 0.007* | 0.15 |
| ER/PR+ | 0.866 | 0.275–2.773 | 0.804 | 0.982 |
| HER2+ | 2.59 | 0.706–10.769 | 0.161 | 0.692 |
| Plasma cell | ||||
| Time after biopsy | 1.002 | 0.965–1.04 | 0.908 | 0.982 |
| Carrier material | 5.5 | 2.002–16.63 | 0.001 * | 0.043* |
| ER/PR+ | 0.542 | 0.163–1.698 | 0.298 | 0.777 |
| HER2+ | 1.366 | 0.374–5.189 | 0.635 | 0.942 |
| Lymphocyte | ||||
| Time after biopsy | 1.036 | 0.974–1.117 | 0.307 | 0.777 |
| Carrier material | 1.6 | 0.35–7.329 | 0.532 | 0.88 |
| ER/PR+ | 2.65 | 0.491–12.406 | 0.222 | 0.771 |
| HER2+ | 1.078 | 0.216–4.26 | 0.919 | 0.982 |
| Macrophage | ||||
| Time after biopsy | 1.017 | 0.975–1.066 | 0.444 | 0.878 |
| Carrier material | 1.53 | 0.526–4.437 | 0.43 | 0.878 |
| ER/PR+ | 1.571 | 0.43–5.259 | 0.472 | 0.878 |
| HER2+ | 0.928 | 0.235–4.622 | 0.919 | 0.982 |
Days after biopsy (continuous variable), interval between diagnostic biopsy to surgery; Carrier material, residual carrier material from biopsy marker; CI, confidence interval; FDR, false discovery rate. Asterisk indicates statistical significance, p < 0.05.